Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Cubbon

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Diabetes/Metabolism Research and Reviews|September 19, 2012
Cell-specific insulin resistance: implications for atherosclerosisA Rajwani, R M Cubbon, S B Wheatcroft
International Journal of Clinical Practice|June 16, 2012
Diabetes mellitus and the heartB N Mercer, S Morais, R M Cubbon, et al.
Cytokine|June 17, 2000
Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?P L Podolin, M B Wilusz, R M Cubbon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401C M Hill, A Liu, K W Marshall, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolateA B Jones, J J Acton, M N Rivetna, et al.
Heart (British Cardiac Society)|March 21, 2014
Prospective development and validation of a model to predict heart failure hospitalisationR M Cubbon, A Woolston, B Adams, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Diabetes/Metabolism Research and Reviews|September 19, 2012
Cell-specific insulin resistance: implications for atherosclerosisA Rajwani, R M Cubbon, S B Wheatcroft
International Journal of Clinical Practice|June 16, 2012
Diabetes mellitus and the heartB N Mercer, S Morais, R M Cubbon, et al.
Cytokine|June 17, 2000
Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?P L Podolin, M B Wilusz, R M Cubbon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401C M Hill, A Liu, K W Marshall, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolateA B Jones, J J Acton, M N Rivetna, et al.
Heart (British Cardiac Society)|March 21, 2014
Prospective development and validation of a model to predict heart failure hospitalisationR M Cubbon, A Woolston, B Adams, et al.
Pageof 1